<DOC>
	<DOC>NCT00333372</DOC>
	<brief_summary>To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.</brief_summary>
	<brief_title>To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>Postprandial fullness, upper abdominal bloating and/or early satiety should be at least moderate for 2 days or more at the 7 days at Visit 1 upper abdominal pain, upper abdominal discomfort, postprandial fullness, upper abdominal bloating, early satiety, nausea, vomit and belching should be at least moderate for at least 2 symptoms for 2 days or more at the 7 days at Visit 1 subjects taht heartburn should be the most bothersome symptom Subjects presenting with primary complaints relieved by stool movements (IBS) Subjects with diabetes by treatment Subjects taht heartburn should be more than moderate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>